TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/28/2025
Back to search
Official data from USPTO
ZEALAND PHARMA A/S
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ZEALAND PHARMA A/S
ST13
US500000086842067Class
1, 5, 42, 44
Filing
86842067
Registration
5597662
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
61
Latest update
08/30/2025
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
12/08/2015
Registration date
10/30/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/28/2025
Last transaction
08/30/2025
Responsible office
United States Patent and Trademark Office
Status code
704
Official register
Supplemental Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
Søborg, DK
Examiner
KEELEY, ALISON
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Zealand Pharma A/S
Zealand Pharma A/S
Representatives
Miriam D. Trudell Davis Graham & Stubbs LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
(Based on Section 44(e)) Biomedical compoundspeptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; peptide substrates used in analyzing and detecting certain toxins for laboratory or research use
Class 5
(Based on Section 44(e)) Pharmaceutical preparations for the treatment of diseasesillnesses and ailments in humans and animalsendocrine disordersnutritional and metabolic diseasesimmunity disordersblood disordersdisorders of the nervous system and sensory organsmusculoskeletal system disordersconnective tissue disorderscirculatory system disordersrespiratory system disordersdigestive system and genitourinary system disordersskin disorders; chemical preparations for medical and pharmaceutical purposesfor the treatment of diseasesillnesses and ailments in humans and animalsendocrine disordersnutritional and metabolic diseasesimmunity disordersblood disordersdisorders of the nervous system and sensory organsmusculoskeletal system disordersconnective tissue disorderscirculatory system disordersrespiratory system disordersdigestive system and genitourinary system disordersskin disorders; first aid kits; diagnostic kits comprised of pharmaceutical and chemical preparations for the treatment of diseasesillnessesailments in humans and animalsendocrine disordersnutritional and metabolic diseasesimmunity disordersblood disordersdisorders of the nervous system and sensory organsmusculoskeletal system disordersconnective tissue disorderscirculatory system disordersrespiratory system disordersdigestive system and genitourinary system disordersskin disorders
Class 42
(Based on Section 44(e)) Scientific and technological services and research and design relating thereto in the field of medicinepharmaceuticalsgeneticsbiology and biotechnologyresearchdesign of peptides and pharmaceutical drugsmedical and scientific laboratory servicesscientific and medical research consulting servicesmedical researchanalysis and testing in the field of diseasesillnesses and ailments in humans and animals for scientific and research purposesin the fields of endocrine disordersnutritional and metabolic diseasesimmunity disordersblood disordersdisorders of the nervous system and sensory organsmusculoskeletal system disordersconnective tissue disorderscirculatory system disordersrespiratory system disordersdigestive system and genitourinary system disordersskin disorders; industrial analysis and research services in the field of medicinepharmaceuticalsgeneticsbiology and biotechnology; design and development of computer hardware and software; medicalbiologicalbiotechnologicalgeneticlaboratory and pharmaceutical researchdesign and development servicesthe development of medicines for the treatment of diseasesillnesses and ailments in humans and animalsendocrine disordersnutritional and metabolic diseasesimmunity disordersblood disordersdisorders of the nervous system and sensory organsmusculoskeletal system disordersconnective tissue disorderscirculatory system disordersrespiratory system disordersdigestive system and genitourinary system disordersskin disorders; laboratory research in the field of medicinepharmaceuticalsgeneticsbiology and biotechnology; information and consultancy services relating to all the aforesaidinformation and consultancy services relating to the development of medicines for the treatment of diseasesillnesses and ailments in humans and animalsendocrine disordersnutritional and metabolic diseasesimmunity disordersblood disordersdisorders of the nervous system and sensory organsmusculoskeletal system disordersconnective tissue disorderscirculatory system disordersrespiratory system disordersdigestive system and genitourinary system disordersskin disorders
Class 44
(Based on Section 44(e)) Medical services; veterinary services; hygienic and beauty care for human beings or animals; horticulture services; dentistry services; medical analysis of peptide based medicines for the diagnosis and treatment of persons; pharmaceutical advice; medical consulting services in the field of diseasesillnesses and ailments in humans and animalsendocrine disordersnutritional and metabolic diseasesimmunity disordersblood disordersdisorders of the nervous system and sensory organsmusculoskeletal system disordersconnective tissue disorderscirculatory system disordersrespiratory system disordersdigestive system and genitourinary system disordersskin disorders
Publications
History of USPTO decisions and trademark events.
61 publications found
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
08/28/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/28/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/28/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/28/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/28/2025
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
07/28/2025
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
07/28/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/21/2025
ES8R
TEAS SECTION 8 RECEIVED
10/22/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/30/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/23/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/04/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/23/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/23/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/23/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/23/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/23/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/23/2021
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
10/30/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/25/2018
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
09/25/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/24/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/24/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/24/2018
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
05/29/2018
GNSF
SUBSEQUENT FINAL EMAILED
05/29/2018
CFRC
SUBSEQUENT FINAL REFUSAL WRITTEN
05/29/2018
DOCK
ASSIGNED TO EXAMINER
05/08/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/05/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/05/2018
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
11/21/2017
GPRA
PRIORITY ACTION E-MAILED
11/21/2017
CPRA
PRIORITY ACTION WRITTEN
11/21/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/27/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/27/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/23/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/28/2017
GNFR
FINAL REFUSAL E-MAILED
04/28/2017
CNFR
FINAL REFUSAL WRITTEN
04/28/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/06/2017
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/25/2017
ALIE
ASSIGNED TO LIE
01/23/2017
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/29/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/07/2016
GNRT
NON-FINAL ACTION E-MAILED
10/07/2016
CNRT
NON-FINAL ACTION WRITTEN
10/07/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/16/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/16/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/16/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/16/2016
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/16/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/30/2016
GNRT
NON-FINAL ACTION E-MAILED
03/30/2016
CNRT
NON-FINAL ACTION WRITTEN
03/30/2016
DOCK
ASSIGNED TO EXAMINER
03/25/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/11/2015
NWAP
NEW APPLICATION ENTERED
12/11/2015
Continuous trademark protection
Get notified about every new filing that threatens ZEALAND PHARMA A/S or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.